Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 3, 2006, Pages 393-394

  Guiard Schmid, Jean Baptiste ^a   Poirier, Jean Marie ^b   Bonnard, Philippe ^a   Meynard, Jean Luc ^c  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ATAZANAVIR; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; RABEPRAZOLE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DRUG BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; PRIORITY JOURNAL;

ANTACIDS; DRUG INTERACTIONS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; OLIGOPEPTIDES; PROTON PUMPS; PYRIDINES; RITONAVIR;

EID: 33645107568     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000197075.56397.a5     Document Type: Letter

References (5)

1. 2 blockers. J Acquir Immune Defic Syndr. 2005;39:503.
2. Agarwala S, Gray K, Wang Y, et al. Pharmacokinetic effect of omeprazole on atazanavir with ritonavir in healthy subjects [abstract P658]. Presented at: 12th Conference on Retroviruses and opportunistic Infections; 2005; Boston.
3. Guiard-Schmid JB, Bonnard P, Poirier JM, et al. Nonsignificant drug interaction between atazanavir and proton pump inhibitors in ritonavir boosted regimen. AIDS. 2005;19:1937-1938.
4. Kosel BW, Storey SS, Collier AC. Lack of interaction between atazanavir and lansoprazole. AIDS. 2005;19:637-638.
5. Antoniou T, Yoong D, Beique L, et al. Impact of acid-suppressive therapy on virologie response to atazanavir-based regimen in antiretroviral experienced patients: a case series. J Acquir Immune Defic Syndr. 2005;39:126-128.